Natus Medical Inc (NTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,910 | 24,354 | 23,057 | 19,500 | 16,957 |
| Receivables | 87,557 | 93,005 | 89,960 | 82,030 | 58,137 |
| Inventories | 38,906 | 38,028 | 40,756 | 40,755 | 25,685 |
| Income taxes - deferred | 8,631 | 8,676 | 8,719 | 5,345 | 5,027 |
| TOTAL | $169,979 | $169,858 | $168,871 | $157,119 | $168,366 |
| Non-Current Assets | |||||
| PPE Net | 25,842 | 25,994 | 26,512 | 28,511 | 26,840 |
| Intangibles | 200,544 | 202,251 | 188,642 | 195,556 | 146,116 |
| Other Non-Current Assets | 8,445 | 9,681 | 7,828 | 7,968 | 6,911 |
| TOTAL | $234,831 | $237,926 | $222,982 | $232,035 | $179,867 |
| Total Assets | $404,810 | $407,784 | $391,853 | $389,154 | $348,233 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 8,522 | 8,526 | 8,528 | 8,521 |
| Accounts payable and accrued liabilities | 25,811 | 29,249 | 32,537 | 31,885 | 15,809 |
| Accrued Expenses | 24,007 | 27,590 | 32,938 | 35,000 | 19,449 |
| TOTAL | $71,951 | $112,725 | $98,606 | $94,478 | $57,498 |
| Non-Current Liabilities | |||||
| Long Term Debt | 40,381 | 10,892 | 13,034 | 15,173 | 17,279 |
| Deferred Revenues | 11,951 | 14,064 | 13,305 | 11,765 | 7,719 |
| Other Non-Current Liabilities | 3,779 | 2,401 | 3,038 | 4,723 | 5,209 |
| TOTAL | $53,501 | $22,127 | $24,495 | $34,821 | $31,470 |
| Total Liabilities | $125,452 | $134,852 | $123,101 | $129,299 | $88,968 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,746 | 30,387 | 30,339 | 29,952 | 29,851 |
| Common Shares | 281,867 | 278,463 | 275,395 | 272,577 | 270,193 |
| Retained earnings | 19,101 | 15,081 | 11,638 | 6,032 | 7,973 |
| Other shareholders' equity | -21,610 | -20,612 | -18,281 | -18,754 | -18,901 |
| TOTAL | $279,358 | $272,932 | $268,752 | $259,855 | $259,265 |
| Total Liabilities And Equity | $404,810 | $407,784 | $391,853 | $389,154 | $348,233 |